Lyell Immunopharma LYEL Growth Metrics (2020-2026)

NASDAQ LYEL
$9.43 +0.02 (+0.16%)
As of: Oct 22, 2026 · 3:25 PM EDT
Reported Financials

Lyell Immunopharma Quarterly Growth Metrics

Periods 24 quarters
Latest Jun 2026

Lyell Immunopharma reported revenue growth of -50.00% and asset growth of -19.28% for the quarter ended Jun 2026. These growth metrics cover 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
24.13%-16.93%-18.45%-16.84%-17.88%-18.24%-18.65%-20.00%-21.15%-21.69%-22.11%-34.55%-38.09%-41.08%-34.12%-30.72%-18.42%-19.28%
Assets Growth (3y)
-6.18%-18.98%-19.75%-24.21%-26.26%-27.74%-25.26%-28.68%-26.43%-28.05%
Assets Growth (5y)
-17.84%-24.03%
Assets (QoQ)
-2.56%-5.92%-4.91%-4.70%-4.35%-4.06%-6.09%-5.12%-4.83%-5.66%-7.44%-5.77%-5.34%-20.73%-12.44%-10.32%5.84%-16.65%3.11%-11.26%
Capital Expenditures Growth (1y)Capex Growth (1y)
-8.24%-58.73%-49.28%-70.67%-75.94%-55.38%-84.25%-86.99%-93.01%-99.45%-98.04%-64.52%-69.74%76.00%720.00%-49.24%5.08%590.91%-63.82%52.38%
Capital Expenditures Growth (3y)Capex Growth (3y)
-75.11%-89.98%-88.39%-76.17%-82.80%-83.76%-70.65%-71.38%-71.89%-59.52%-61.28%-35.02%
Capital Expenditures Growth (5y)Capex Growth (5y)
-65.48%-58.56%-65.86%-59.82%
Capital Expenditures (QoQ)Capex (QoQ)
-52.55%-11.48%-5.21%-26.33%-61.07%64.17%-66.54%-39.14%-79.10%-87.18%20.00%1,003.33%-82.18%-25.42%459.09%-31.71%-63.10%390.32%-70.72%187.64%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
191.75%109.27%-8.91%-63.55%-70.44%-57.95%-50.84%9.06%146.08%17.88%14.83%-40.53%-64.96%-27.50%-4.24%-25.95%23.21%-43.01%-24.56%-26.13%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-3.08%28.50%1.23%-19.89%-38.17%-36.60%-28.90%-18.54%-21.69%2.04%-21.32%-6.04%-31.23%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-16.70%-1.74%-15.59%-17.97%-33.58%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-30.28%-25.33%-24.24%-7.57%-43.47%6.23%-11.43%105.04%27.56%-49.11%-13.73%6.19%-24.83%5.28%13.95%-17.89%25.07%-51.30%50.83%-19.59%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-61.11%-328.06%-119.11%163.38%60.61%163.16%223.09%511.18%274.60%-315.85%-31.60%-70.57%-98.08%153.14%215.84%-71.90%74.61%-158.62%-74.98%23.48%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
45.94%-72.23%-45.61%46.44%26.27%39.67%67.02%-20.34%27.21%-38.77%-18.54%-53.26%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
15.29%-24.31%-33.80%19.09%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-267.11%49.03%64.63%195.78%-328.17%181.72%-31.07%375.56%-34.82%-201.02%121.84%104.63%-95.74%2,689.62%29.83%-81.79%-73.52%-1,036.55%155.41%-10.14%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-17.87%-24.24%-42.43%-30.59%-45.55%-21.24%3.43%11.67%-1.57%-0.91%9.08%2.72%7.02%-16.26%-30.28%9.54%18.45%31.73%29.65%1.56%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-20.33%-14.98%-7.74%-3.92%-11.19%-12.46%-4.58%8.06%8.34%7.13%5.90%4.67%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-5.73%-3.83%-2.77%0.01%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
24.91%-30.29%-44.08%7.35%16.31%-8.53%-14.76%15.26%3.77%-7.83%-3.40%9.33%8.01%-34.82%-15.87%37.05%17.07%-12.86%-19.41%11.91%
EBITDA Margin Growth (1y)
0.17M0.01M-0.95M0.22M-205.89M0.15M-7.69M-22.53M184.48M-41.88M-159.65M-13.33M8.10M-136.41M91.47M-19.14M-9.65M-30.45M-132.61M-57.78M
EBITDA Margin Growth (3y)
-21.24M-41.72M-168.28M-35.64M-13.31M-178.14M-75.87M-55.00M182.93M-208.74M-200.79M-90.25M
EBITDA Margin Growth (5y)
-22.79M-208.58M-209.43M-112.56M
EBITDA Margin (QoQ)
0.06M0.01M-1.01M1.16M-206.04M206.05M-8.85M-13.68M0.96M-20.31M-126.62M132.64M22.39M-164.81M101.25M22.03M31.88M-185.62M-0.90M96.86M
EBIT Growth (1y)
-33.43%-20.28%-23.85%40.58%-35.14%68.90%8.78%-76.87%11.14%-302.52%11.16%21.81%14.45%-238.02%-3.22%8.52%26.24%36.54%22.85%-0.42%
EBIT Growth (3y)
13.71%-17.02%-14.61%-0.12%6.34%-0.90%-61.74%5.78%-8.15%17.54%-105.15%10.89%10.44%
EBIT Growth (5y)
14.40%-0.22%-26.42%4.38%5.47%
EBIT Margin Growth (1y)
0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
EBIT Margin Growth (3y)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
EBIT Margin Growth (5y)
-58.60M-24.49M-212.57M-221.08M-118.10M
EBIT Margin (QoQ)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.57M102.96M
EBIT (QoQ)
21.60%3.30%-44.26%45.66%-78.30%77.75%-323.13%-5.35%10.42%-0.79%6.61%7.28%1.99%-298.27%71.48%17.83%20.97%-242.64%65.32%-6.95%
EBT Growth (1y)
-36.77%-20.28%-23.85%40.37%-35.89%68.90%8.78%-76.87%11.14%-302.52%11.16%21.81%14.45%-238.02%-3.22%8.52%26.24%36.54%22.85%-0.42%
EBT Growth (3y)
13.17%-18.20%-14.61%-0.12%6.23%-1.09%-61.74%5.78%-8.15%17.54%-105.15%10.89%10.44%
EBT Growth (5y)
14.08%-0.83%-26.42%4.38%5.40%
EBT Margin Growth (1y)
0.16M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
EBT Margin Growth (3y)
-24.09M-23.28M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
EBT Margin Growth (5y)
-58.60M-24.50M-212.57M-221.08M-118.10M
EBT Margin (QoQ)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.57M102.96M
EBT (QoQ)
21.76%2.77%-44.26%45.66%-78.30%77.75%-323.13%-5.35%10.42%-0.79%6.61%7.28%1.99%-298.27%71.48%17.83%20.97%-242.64%65.32%-6.95%
EPS (Basic) Growth (1y)
99.99%78.99%91.24%89.94%-38.57%94.48%3.87%-73.16%28.48%-520.54%11.06%29.76%14.04%-248.06%25.87%19.56%38.87%43.92%68.79%33.61%
EPS (Basic) Growth (3y)
96.85%95.71%58.41%57.85%50.35%5.20%-6.03%14.10%0.73%27.84%-129.66%40.96%27.88%
EPS (Basic) Growth (5y)
88.80%86.72%32.47%55.57%42.05%
EPS (Basic) (QoQ)
86.07%-201.64%54.69%47.16%-91.85%87.99%-689.39%4.82%20.76%-4.22%-13.14%24.83%3.02%-322.00%75.90%18.43%26.30%-287.16%86.59%-73.50%
EPS (Diluted) Growth (1y)
96.90%78.99%91.24%89.94%-38.57%94.48%3.87%-73.16%28.48%-520.54%11.06%29.76%14.04%-248.06%25.87%19.56%38.87%43.92%68.79%33.61%
EPS (Diluted) Growth (3y)
76.03%68.67%58.41%57.85%50.35%5.20%-6.03%14.10%0.73%27.84%-129.66%40.96%27.88%
EPS (Diluted) Growth (5y)
62.14%56.18%32.47%55.57%42.05%
EPS (Diluted) (QoQ)
86.07%-201.64%54.69%47.16%-91.85%87.99%-689.39%4.82%20.76%-4.22%-13.14%24.83%3.02%-322.00%75.90%18.43%26.30%-287.16%86.59%-73.50%
FCF Margin Growth (1y)
0.19M0.07M-0.83M0.21M-132.85M0.14M-6.30M-14.84M117.83M-31.27M-132.81M-14.71M4.83M-11.71M61.60M-13.72M-8.77M-11.27M-114.45M-42.16M
FCF Margin Growth (3y)
-14.83M-31.05M-139.94M-29.34M-10.19M-42.83M-77.51M-43.27M113.89M-54.25M-185.65M-70.60M
FCF Margin Growth (5y)
-18.77M-54.04M-192.78M-85.22M
FCF Margin (QoQ)
0.09M-0.02M-0.89M1.03M-132.97M132.97M-7.34M-7.50M-0.30M-16.12M-108.88M110.60M19.23M-32.66M-35.56M35.27M24.19M-35.17M-138.74M107.55M
Free Cash Flow Growth (1y)FCF Growth (1y)
-8.23%15.76%-9.09%11.80%-7.56%-3.15%17.09%22.15%5.05%9.34%11.94%4.16%7.34%-16.30%-30.77%9.89%18.41%31.15%29.80%1.29%
Free Cash Flow Growth (3y)FCF Growth (3y)
-3.40%7.64%7.30%13.02%1.82%-2.84%1.53%12.40%10.46%10.13%6.84%5.18%
Free Cash Flow Growth (5y)FCF Growth (5y)
3.53%8.80%6.07%10.16%
Free Cash Flow (QoQ)FCF (QoQ)
36.48%-17.23%-32.44%10.56%22.54%-12.42%-6.46%16.02%5.52%-7.34%-3.41%8.61%8.65%-34.71%-16.28%37.03%17.29%-13.67%-18.57%11.45%
Net Cash Flow Growth (1y)NCF Growth (1y)
-53.25%-1,763.21%-168.70%-105.27%47.68%107.27%80.22%781.89%169.15%-2,040.45%-41.54%-93.24%-153.56%104.77%173.66%-378.17%174.79%-1,046.18%107.69%17.77%
Net Cash Flow Growth (3y)NCF Growth (3y)
36.70%-194.17%-29.91%-71.04%42.13%27.39%30.18%-8.66%31.56%-120.71%60.90%-29.16%
Net Cash Flow Growth (5y)NCF Growth (5y)
17.31%-65.93%-21.70%-15.50%
Net Cash Flow (QoQ)NCF (QoQ)
-153.41%41.69%28.35%76.40%-430.51%108.10%-295.02%913.67%-46.20%-327.29%85.78%138.88%-526.03%120.23%119.84%-246.84%214.54%-355.91%148.25%-158.14%
Net Income Growth (1y)
-36.83%-115.42%-23.80%41.97%-43.74%89.97%1.74%-75.89%27.62%-530.34%9.40%28.30%12.33%-262.62%13.96%6.82%12.87%26.68%53.73%-4.85%
Net Income Growth (3y)
14.06%-12.50%-10.85%-3.30%9.88%3.02%-31.87%8.50%-5.53%17.92%-155.91%28.82%11.19%
Net Income Growth (5y)
15.77%-1.69%-29.35%15.19%6.49%
Net Income (QoQ)
21.92%-71.27%18.59%46.70%-93.41%88.05%-697.42%4.58%20.41%-4.08%-14.62%24.49%2.68%-330.51%72.81%18.22%8.99%-262.26%82.84%-85.30%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-36.83%-115.42%-23.80%41.97%-43.74%89.97%1.74%-75.89%27.62%-530.34%9.40%28.30%12.33%-262.62%13.96%6.82%12.87%26.68%53.73%-4.85%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
14.06%-12.50%-10.85%-3.30%9.88%3.02%-31.87%8.50%-5.53%17.92%-155.91%28.82%11.19%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
15.77%-1.69%-29.35%15.19%6.49%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
21.92%-71.27%18.59%46.70%-93.41%88.05%-697.42%4.58%20.41%-4.08%-14.62%24.49%2.68%-330.51%72.81%18.22%8.99%-262.26%82.84%-85.30%
Net Margin Growth (1y)
0.16M-0.13M-1.01M0.23M-234.00M0.29M-9.07M-23.65M213.84M-40.71M-191.92M-11.57M7.23M-133.77M127.66M-18.12M-12.78M-60.05M-46.20M-58.53M
Net Margin Growth (3y)
-23.34M-20.01M-40.55M-202.00M-35.00M-12.94M-174.19M-73.33M-53.34M208.28M-234.54M-110.46M-88.22M
Net Margin Growth (5y)
-53.03M-25.56M-234.37M-120.54M-111.65M
Net Margin (QoQ)
0.06M-0.12M-0.94M1.22M-234.17M234.18M-10.30M-13.36M3.32M-20.37M-161.51M166.99M22.13M-161.37M99.92M21.21M27.46M-208.64M113.77M8.88M
Operating Income Growth (1y)Op. Inc Growth (1y)
-33.43%-20.28%-23.85%40.58%-35.14%68.90%8.78%-76.87%11.14%-302.52%11.16%21.81%14.45%-238.02%-3.22%8.52%26.24%36.54%22.85%-0.42%
Operating Income Growth (3y)Op. Inc Growth (3y)
13.71%-17.02%-14.61%-0.12%6.34%-0.90%-61.74%5.78%-8.15%17.54%-105.15%10.89%10.44%
Operating Income Growth (5y)Op. Inc Growth (5y)
14.40%-0.22%-26.42%4.38%5.47%
Operating Income (QoQ)Op. Inc (QoQ)
21.60%3.30%-44.26%45.66%-78.30%77.75%-323.13%-5.35%10.42%-0.79%6.61%7.28%1.99%-298.27%71.48%17.83%20.97%-242.64%65.32%-6.95%
Operating Margin Growth (1y)
0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
Operating Margin Growth (3y)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
Operating Margin Growth (5y)
-58.60M-24.49M-212.57M-221.08M-118.10M
Operating Margin (QoQ)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.57M102.96M
Profit After Tax Growth (1y)PAT Growth (1y)
-36.77%-20.28%-23.85%40.37%-35.89%68.90%8.78%-76.87%11.14%-302.52%11.16%21.81%14.45%-238.02%-3.22%8.52%26.24%36.54%22.85%-0.42%
Profit After Tax Growth (3y)PAT Growth (3y)
13.17%-18.20%-14.61%-0.12%6.23%-1.09%-61.74%5.78%-8.15%17.54%-105.15%10.89%10.44%
Profit After Tax Growth (5y)PAT Growth (5y)
14.08%-0.83%-26.42%4.38%5.40%
Profit After Tax (QoQ)PAT (QoQ)
21.76%2.77%-44.26%45.66%-78.30%77.75%-323.13%-5.35%10.42%-0.79%6.61%7.28%1.99%-298.27%71.48%17.83%20.97%-242.64%65.32%-6.95%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
55.88%16.35%8.52%2.44%-5.65%-10.88%-14.02%-16.56%-17.51%-18.10%-18.55%-53.05%-54.83%-57.98%-58.29%-27.86%-25.96%-22.01%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
10.04%-5.31%-8.74%-26.24%-29.42%-32.57%-33.65%-34.37%-34.90%-35.50%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-14.71%-22.57%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
5.67%3.66%4.67%1.47%-1.44%-2.15%-3.60%-4.15%-4.91%-5.03%-4.69%-4.84%-5.42%-45.26%-8.31%-11.49%-6.12%-5.31%-5.90%-6.76%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-500.00-111.0077.00-512.00-282.000.00M0.00M-903.00-929.000.00M0.00M-0.01M-0.01M-740.00411.00986.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-144.00-226.00137.00-267.00246.00-38.00-453.00-37.00-716.00-126.00-23.00-63.000.00M0.00M-905.0094.000.00M-218.00-330.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-528.00-108.0092.00-514.00-275.000.00M0.00M-961.000.00M0.00M-0.01M-0.01M-0.01M0.00M293.00794.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-134.00-229.00121.00-286.00286.00-29.00-485.00-47.00-754.00-133.00-28.00-92.000.00M0.00M0.00M208.000.00M-11.00-503.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M-550.00-26.00273.00-445.00-216.000.00M0.00M0.00M0.00M0.00M-0.01M-0.01M-0.01M0.00M202.000.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M-182.00-276.00200.00-292.00341.0024.00-519.00-63.00-832.00-163.00-43.00-99.000.00M0.00M0.00M290.000.00M-489.00-286.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-58.60M-24.49M-212.57M-221.08M-118.10M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.57M102.96M
Revenue Growth (1y)
157.48%22.06%-77.38%1,260.01%-99.89%1,614.60%-88.25%-99.92%733.33%-99.97%-95.38%-51.85%36.00%-15.38%133.33%-38.46%-55.88%-45.45%-71.43%-50.00%
Revenue Growth (3y)
-79.46%-71.41%-82.22%-89.29%-82.96%-76.89%-84.26%-76.69%-93.93%71.00%-95.01%-68.66%-47.09%
Revenue Growth (5y)
-69.67%-57.41%-69.60%-75.87%-72.68%
Revenue (QoQ)
4.83%2.43%-80.40%6,363.11%-99.99%1,612,766.67%-99.87%-58.46%-7.41%-48.00%-76.92%333.33%161.54%-67.65%-36.36%14.29%87.50%-60.00%-66.67%100.00%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
33.79%63.27%73.01%46.96%46.63%-13.29%-36.98%-36.53%-45.01%-53.91%-34.05%-41.76%-27.52%-4.49%-34.20%-39.59%-31.36%216.33%-28.70%-9.43%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
25.08%2.56%-13.27%-10.41%-18.40%-16.39%-27.46%-35.09%-39.33%-35.08%11.67%-32.37%-31.70%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-7.19%-11.70%14.54%-19.53%-21.55%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-14.47%62.38%4.01%1.73%-14.67%-3.97%-24.40%2.46%-26.06%-19.52%8.18%-9.51%-7.99%6.05%-25.47%-16.93%4.56%388.70%-83.20%5.52%

Lyell Immunopharma Growth Metrics API

Pull Lyell Immunopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LYEL&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY